“SGRT provides the potential to reduce treatment-related errors which could affect patient outcomes, especially within the realm of hypo-fractionated treatments.”
– Juergen Meyer, University of Washington Medical Center and Department of Radiation Oncology, Seattle Cancer Care Alliance, Seattle, WA, USA, and senior author for the study.
C-RAD offers a full range of SGRT solutions, along with robust training, implementation and vendor integration to help ensure the best possible treatment outcome while maximizing efficiency for the treatment team.
You might also be interested in
Expanding Horizons of SGRT Explored by a C-RAD Expert
Jennifer Cook, C-RAD Applications Specialist, Vertec Scientific
Daniel Speir, Chief Radiation Therapist, Willis-Knighton Health System, Shreveport, La. A newly published article by Jennifer Cook, C-RAD Clinical Applications Specialist at Vertec Scientific, a distributor of C-RAD products in…
C-RAD is excited to announce the official opening of the C-RAD India Experience Centre, the first of its kind in Asia and the Middle East. Opened in collaboration with…
Contact us
Contact your local office
We have service support groups the USA, China, Germany, France & Sweden